Victrex CEO Dr. Routh outlines PEEK monopoly, £250m shareholder returns, and conservative 5% growth guidance to 2031
Summary
Dr. James Routh, CEO of Victrex, explains the company's monopoly on Type 1 PEEK polymer and its strategy to restructure from centralized to decentralized operations. He confirms a commitment to return a minimum of £250 million in levered free cash flow to shareholders over five years, funded by a previous dividend cut. Routh provides conservative 5% annual revenue growth guidance to 2031, explicitly excluding mega-projects and humanoid robotics due to uncertainty. Lord Lee of Trafford discusses his investment thesis, citing Routh's appointment and the stock's low valuation, while also updating listeners on his own portfolio moves including Christie Group and Big Yellow.
Key takeaways
- 1 Victrex produces type one, and we're the only people in the world that produce type one peaks. peak.
Unidentified speaker (speaker_2) · 6:39
Episode sections
- 0:05 – 2:24
Introduction and Market Context
Alex Newman and Lord Lee discuss the podcast format and Lord Lee's preference for equities over bonds, citing a 5.5% yield on equities as sufficient. They introduce the guest, Dr. James Routh, CEO of Victrex.
- 2:24 – 8:37
Victrex Product and Market Position
Dr. Routh explains Victrex manufactures PEEK, an ultra-high-performance polymer used in aerospace, medical implants, and robotics due to its heat resistance, fatigue resistance, and biocompatibility. He distinguishes Victrex's 'Type 1' PEEK from competitors' 'Type 2' PEEK, noting Victrex is the sole producer of Type 1.
- 8:37 – 17:53
Turnaround Strategy and Leadership
Lord Lee discusses his investment thesis based on Dr. Routh's appointment and the stock's low valuation. Dr. Routh outlines his strategy to restructure the business from centralized to decentralized, focusing on 'Transform, Grow, and Optimize' to improve sales and operational efficiency.
- 17:53 – 25:08
Dividend Cut and Capital Allocation
Dr. Routh explains the dividend cut was necessary because the previous dividend was uncovered and funded by debt. He commits to returning a minimum of £250 million of levered free cash flow to shareholders over five years, with surplus returned via buybacks or special dividends.
- 25:08 – 28:52
Growth Opportunities and Guidance
Dr. Routh discusses growth in aerospace, defense, and medical sectors, excluding 'mega projects' from his conservative 5% annual revenue growth guidance to 2031. He addresses humanoid robotics as a potential future opportunity, noting current usage in prototypes but excluding it from formal guidance due to uncertainty.
- 28:52 – 35:33
Competitive Positioning and Geopolitical Risks
Dr James Routh explains Victrex's strategy of engaging customers early in the design cycle to entrench their PEEK solution, raising barriers to entry. He notes that while Chinese competitors exist, Victrex has maintained market share and lost virtually no business outside China due to superior synthesis capabilities.
- 35:33 – 37:18
Energy Costs and Business Model
Routh clarifies that Victrex is a high-margin specialized materials company, not a commodity chemical firm, with energy costs representing only about 4% of revenue. He confirms the Lancashire plant uses both gas and electricity, but the impact of energy price volatility is less severe than for higher-volume commodity peers.
- 37:18 – 38:56
CEO Optimism and Shareholder Alignment
Dr Routh rates his optimism for Victrex at a nine or ten out of ten, citing successful restructuring, leadership improvements, and clear financial guidance. He confirms he acquired shares before starting in January and holds share options, aligning his interests with shareholders to drive the share price up to deter predators.
- 38:56 – 44:23
Lord Lee's Portfolio Update and New Positions
Lord Lee explains selling the bulk of his Goodwin holding due to uncertainties surrounding the defense business sale and new management appointments. He has redeployed capital into Christie Group, Vionet, Big Yellow, NWF, and Bank of Ireland, citing undervaluation, strong yields, and activist interest as key drivers.
- 44:23 – 47:01
Cerulean Holdings and Near-Term Outlook
Lord Lee remains invested in Cerulean despite a share price drop from £20 to ~£7, citing a short-term plateau in new orders. He views a recent £140k purchase by a founding non-executive director as a strong signal of confidence and expects a significant recovery if new contracts are announced soon.
Claims worth verifying
Lord Lee states he likes 5.5% yields but gets them on equities, preferring to remain 100% equities.
Lord Lee of Trafford ·0:54
How to verify: Check UK government bond (gilts) yields for the relevant period (Nov 2026) and compare to Victrex dividend yield or equity risk premium discussions in Investors' Chronicle archives. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Victrex is the only producer of 'Type 1' PEEK; all other producers make 'Type 2' PEEK.
Unidentified speaker (speaker_2) ·6:39
How to verify: Review Victrex investor presentations or technical white papers on PEEK polymer grades (Type 1 vs Type 2) and manufacturing processes. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Less than 2% of Victrex's business is in the UK.
Unidentified speaker (speaker_2) ·11:19
How to verify: Check Victrex annual reports or segment reporting for geographic revenue breakdown. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Victrex has double production capacity and can double revenue without adding capex.
Unidentified speaker (speaker_2) ·11:00
How to verify: Review Victrex capital markets event presentation or annual reports for production capacity figures and capex guidance. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Victrex commits to returning a minimum of £250 million of levered free cash flow to shareholders over a five-year horizon.
Unidentified speaker (speaker_2) ·18:41
How to verify: Review Victrex capital markets event presentation or press release dated around Nov 2026 outlining capital allocation policy. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Revenue growth guidance of 5% per annum to 2031 excludes 'mega programs' like magma and knee.
Unidentified speaker (speaker_2) ·22:50
How to verify: Review Victrex financial guidance documents or capital markets event slides for the definition of the guidance base case. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Norges Bank holds approximately 9-10% of Victrex.
Unidentified speaker (speaker_2) ·19:47
How to verify: Check UK regulatory shareholding notifications (RNS) filed by Victrex or Norges Bank's quarterly holdings reports. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Columbia Thread Needle is Victrex's largest shareholder.
Unidentified speaker (UNKNOWN) ·19:52
How to verify: Check UK regulatory shareholding notifications (RNS) filed by Victrex for top 20 shareholder list. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Barclays published a note with large volume forecasts for humanoid robotics using PEEK.
Unidentified speaker (speaker_2) ·26:32
How to verify: Search Barclays Research archives for notes on humanoid robotics and PEEK demand forecasts published around Nov 2026. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Victrex has no competitors for PEEK type one, but faces two Western competitors and seven Chinese competitors for PEEK type two.
Unidentified speaker (UNKNOWN) ·31:52
How to verify: Victrex annual report or investor presentation detailing product grades and competitive landscape. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
One Chinese competitor has around 1,500 tons of capacity and a reliable product.
Unidentified speaker (speaker_2) ·32:23
How to verify: Industry reports on PEEK capacity or Victrex competitor analysis in investor presentations. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
The Chinese government announced a 13% VAT on all exports of PEEK from the UK.
Unidentified speaker (speaker_2) ·33:36
How to verify: UK government or Chinese customs records regarding export taxes on polymers; Victrex investor materials on trade policy. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Energy costs represent around 4% of Victrex's revenue.
Unidentified speaker (speaker_2) ·36:10
How to verify: Victrex annual report or management presentation detailing cost structure and energy expenditure. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
The UK accounts for only 2% of Victrex's revenue.
Lord Lee of Trafford ·31:28
How to verify: Victrex annual report or segmental revenue disclosure. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Victrex share price increased approximately 60% since June.
Unidentified speaker (UNKNOWN) ·34:49
How to verify: Stock price data for Victrex (LSE: VCT) comparing June 2026 to November 2026. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Lord Lee sold the bulk of his Goodwin holding due to concerns over the defense business sale and new CEO/Finance Director appointments.
Unidentified speaker (UNKNOWN) ·39:05
How to verify: Goodwin regulatory filings (RNS) regarding management changes and Lord Lee's shareholding disclosures. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Primary sourceLord Lee bought Big Yellow at £8 when asset value was £12.
Lord Lee of Trafford ·41:57
How to verify: Big Yellow share price history and net asset value reports from 2026. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
A founding non-executive director of Cerulean bought £140,000 of shares at around £7.
Lord Lee of Trafford ·45:38
How to verify: Cerulean insider dealing notifications (RNS) filed with the FCA. For recent events, verify 2026-08-10 through 2026-11-10. Use another period only when the speaker explicitly names it.
Do your own research
- Verify Victrex's annual report and 2026 interim results for the actual levered free cash flow figures and the £250m return commitment details.
- Check the UK Companies House filing for the dividend cut resolution and the specific debt levels prior to the restructuring.
- Review Victrex's latest investor presentation for the breakdown of the 5% revenue growth guidance and the excluded 'mega programs' (e.g., magma oil/gas pipes, knee medical program).
- Analyze the Barclays report referenced by Dr. Routh regarding humanoid robotics volume forecasts to compare internal vs. external expectations.
- Examine Victrex's supply chain disclosures to confirm the UK's share of revenue (<2%) and the specific energy cost percentage (4%).
- Check Lord Lee's portfolio holdings via his fund's latest quarterly filing to verify positions in Christie Group, Vionet, Big Yellow, NWF, and Bank of Ireland.
- Review Cerulean Holdings' latest trading update for order book status and the share price at the time of the £140k insider purchase.
- Compare Victrex's Type 1 PEEK specifications and pricing against competitor Type 2 PEEK data from industry reports or competitor filings.
Full transcriptexpand
- 0:05
- Alex Newman: Hello and welcome to Lee and the IC, the monthly podcast in which you get to hear from one of the UK's leading DIY investors and the heads of the companies he invests in. It's Monday, the second of November, as we record. I'm Alex Newman, an associate editor at the Investors Chronicles, sitting across from Lord Lee of Trafford. John, how are you today?
- 0:24
- Lord Lee of Trafford: Fine, thank you. Fine.
- 0:26
- Unidentified speaker (UNKNOWN): A
- 0:26
- Alex Newman: less dramatic budget, perhaps, last week, but there's been no end of market drama. I mean, one question we've rarely addressed on this podcast, one which we're always asking the magazine, is the point at which guilts or bonds start to look attractive. I know you're I know you're an equity man, I know you're a dividend man, so this may be an entirely moot question.
- 0:46
- Alex Newman: The stock market has served you well over the years, but is your head ever turned by long-term long term yields? at five point five percent or do you just stick to the knitting and
- 0:54
- Lord Lee of Trafford: I I like five point five percent yields, but I can get them on equities. I don't need to go to guilds. Okay. I'm as you say I'm a hundred percent equities man and I think I will always die that way.
- 1:03
- Alex Newman: Okay. Perfect. So that nips that one in the bud. We can get onto the meat of the uh the podcast. We'll we'll touch on the end uh some of the proceeds of a a big sale I know you've made into into several new holdings and we can look at the the portfolio then. Before then, I've got two things to do. The first is to remind listeners that everything we talk about on this podcast is for the purposes of
- 1:23
- Alex Newman: education and entertainment, and none of it should be taken as financial advice or a recommendation to buy or sell shares. And the second is to introduce this month's guest, Dr. James Routh, Chief Executive of FTSE250 speciality chemicals firm Victrex. the ticker's VCT. James has very generously made the journey from the I was gonna say
- 1:43
- Alex Newman: from the company's Lancashire headquarters to the Financial Times studio, but I hear there is also an outpost in Farringdon, so not quite as far uh to be with us. James, we're really grateful for you being here today. Welcome. Let's start with the the basics. Victrex is by the standards of some of the companies we've we've had in uh uh on
- 2:03
- Alex Newman: this podcast a fairly big beast. Uh but while I'm sure many listeners will know the business and know what know what you do, um your products are are both very bespoke and highly technical in nature. So let's let's start basic. Can you please please tell us, and for those who are new to the company, what it is you manufacture, who your customers are, and the problems you're trying to
- 2:23
- Alex Newman: solve for them.
- 2:24
- Unidentified speaker (speaker_2): Yeah, Yep, sure.
- 2:25
- Unidentified speaker (UNKNOWN): Well, hi
- 2:26
- Unidentified speaker (speaker_2): Alex, thanks for having me. me on. We supply a product called Peak, which is polyether ether ketone. That's about as technical as I'm going to
- 2:34
- Unidentified speaker (UNKNOWN): get on
- 2:35
- Unidentified speaker (speaker_2): this podcast. It's basically an ultra high performance polymer that's used in really demanding applications where properties like high temperatures, wear, Where chemical resistance, and repeated loading make conventional materials unsuitable.
- 2:51
- Unidentified speaker (speaker_2): And suppose the key characteristics of peak are heat and repeated loading, so fatigue resistance at high temperatures, chemical resistance, so it's compatible with lots of different types of chemicals. Its ability to withstand wear is really, really important. So applications like robotics, where you've got wear surfaces, are
- 3:11
- Unidentified speaker (speaker_2): really important.
- 3:13
- Unidentified speaker (speaker_2): Its strength to weight rate. ratio is also really important as well. So that's why it's used in various aerospace applications now in thermoplastic composites, where it's got excellent strength to weight ratio, long term durability, and it's really much easier to manufacture than conventional materials in aerospace composites.
- 3:31
- Unidentified speaker (UNKNOWN): And
- 3:31
- Unidentified speaker (speaker_2): I suppose the final part that really is important for us is its medical suitability. It's biocompatible, it can be used in implants. implantable applications inside the body. And then we've got a long-term proven track record in that particular area.
- 3:46
- Unidentified speaker (UNKNOWN): Great.
- 3:46
- Alex Newman: So I mean it's kind of in broad brush, are you looking to s to replace metal components in in some of your end use applications? Is that what is that what your is that what
- 3:57
- Unidentified speaker (UNKNOWN): polymers tend to
- 3:58
- Alex Newman: polymers tend to do?
- 3:59
- Unidentified speaker (speaker_2): In some cases, yes. I mean if you think about aerospace structures where traditional traditionally aluminium has been used and then it moved to composites. In some cases that's the case, particularly in implantable devices in the body, in orthopedics, where you might have a a a traditional metallic knee joint or other materials that's moving to polymers as well. So it's a var a variety of applications, some cases
- 4:19
- Unidentified speaker (speaker_2): replacing metals, some cases it's the only option really for long long-term term performance in things like oil and gas applications.
- 4:27
- Alex Newman: Okay. And I mean we've I think we've talked about one polymer on this uh on this podcast before that that being a Goodwins developer, which I know is quite early stage, it they're sort of developing the the product. Some listeners might be more familiar with some of the products that DuPont put out. Can you sort of sketch where you sit uh you know, you don't have to comment on your competitor products, but where where do you sit in,
- 4:47
- Alex Newman: you know, in relation to some of the other high performance products that you are competing against?
- 4:52
- Unidentified speaker (speaker_2): Sure, we we often talk about polymers in a and a hierarchy in a pyramid. So you've got the ultra sort of high volume, low performance polymers that you might see in things like packaging right at the bottom, all the way up to the top, which are the ultra high performance polymers, and that's where we sit. Um Peak is often known as the polymer of last resort because it's
- 5:11
- Unidentified speaker (speaker_2): incredibly expensive in comparison to others. But it's still it only makes up around sort of five to ten percent of the cost of a part when it's made. So even though it's expensive, its performance often outweighs its cost. So in relation to some of those other polymers, um, there's there's a few that sit at the top. Peak is at the peak. And and really the thing with Peak is it's
- 5:31
- Unidentified speaker (speaker_2): its combination of properties. So there are certain polymers that might have really good capability in one. of those requirements. So, for example, really high temperature. But peak is a got a unique combination of properties that give it a wider range of applications than some of those examples that you mentioned earlier. So if it's extreme high temperature,
- 5:51
- Unidentified speaker (speaker_2): that particular reference from Goodwin is a good example of where that plays. But it's a combination of broader properties in terms of fatigue resistance, strength, temperature, chemical compatibility, being able to put it inside the body for example, makes it a broader uh uh supply scope of supply for that particular polymer.
- 6:08
- Alex Newman: Great. And I you I mean you've said as well that I think in your your your your marketing materials, you've said that Victrex has got structural advantages that competitors cannot replicate.
- 6:19
- Unidentified speaker (UNKNOWN): But
- 6:19
- Alex Newman: you but you also share the peak P E E K market with other uh manufacturers who also make verbal. versions of your products.
- 6:29
- Unidentified speaker (UNKNOWN): I
- 6:29
- Alex Newman: mean, it
- 6:30
- Unidentified speaker (UNKNOWN): it
- 6:30
- Alex Newman: sounds like you think you've got the best product. Well, does that automatically translate into strong market share given that you are also competing against other peak producers?
- 6:39
- Unidentified speaker (speaker_2): Yes and no. I mean, historically, the peak market is often referred to as two different types of peak, type one and type two. Victrex produces type one, and we're the only people in the world that produce type one peaks. peak.
- 6:51
- Unidentified speaker (UNKNOWN): And
- 6:52
- Unidentified speaker (speaker_2): that's our proprietary monomer manufacturing process that we have here in the UK. So we make our own monomer and we turn that into polymer up at our site in Lancashire. Everybody else does type two, whether they're Chinese competition or other Western suppliers. And it's not to say necessarily that type one is better than type two, it's just different. So if you
- 7:12
- Unidentified speaker (speaker_2): have unique applications where type one is needed, those properties are needed, then VictorXPeak is far more suited to those applications. And therefore that does translate easier into winning market share. If it is a requirement where type one or type two will do for the application, then it's more of a competitive scenario.
- 7:31
- Unidentified speaker (UNKNOWN): And
- 7:31
- Alex Newman: on one final point on that before I obviously Obviously, I I I'd like to bring John in John in. Um just to round out that point, I mean obviously having the best product. and I suppose the lead brand is is clearly a positive, but you know, you're not you're not a luxury goods company. Material science science is all about trade offs. How much pricing power does type
- 7:51
- Alex Newman: one peak give you?
- 7:52
- Unidentified speaker (speaker_2): For those specific applications, it does give pricing power, of course. So that does help. But it's more than that. It's security of supply, it's quality, and it's transitioning. translating these unique properties of Victrex Peak into real world applications through applications engineering is where Victrex really now is starting to focus and excel. So we have
- 8:12
- Unidentified speaker (speaker_2): lots of chemists, lots of material scientists creating these new materials, but actually the real value comes in taking those properties and applying it to a real world customer problem that they struggle solving themselves. So we partner with customers, we do a lot of modeling and simulation, we help them design, we do the regulatory testing. It's all these value added services around
- 8:32
- Unidentified speaker (speaker_2): the offering that adds value and and enhances pricing.
- 8:37
- Alex Newman: Um John, I think I think it's fair to say every comp every company we speak to here is is fairly, fairly unique. There are some themes though, often UK based companies that
- 8:46
- Unidentified speaker (UNKNOWN): are, you know,
- 8:47
- Alex Newman: sort of global leaders in in in in niche niche applications or products. What was it that drew you to Victrex? Have you been inv an investor in the past as well?
- 8:56
- Unidentified speaker (UNKNOWN): No. Uh
- 8:57
- Lord Lee of Trafford: I've never been investor. Didn't really know it well. But what I did know was that in the past, going back, it it was really highly rated. Uh and when I looked at it more recently, some months ago, uh, you know, the price seemed to me to be to be bumping along the bottom. And it had a on the face of it a an attractive yield,
- 9:17
- Lord Lee of Trafford: and query whether that was sustainable or or not. But I didn't see any further downside to it, as it were. Uh, and then I saw that that um Dr. Routh had uh had had moved in as chief executive and was already starting to bring about significant changes. And what I've learned
- 9:36
- Lord Lee of Trafford: over the years is is that and it's fairly obvious, really, that one man uh can can make or break uh a business uh or an or any organization. It's all about that that top person. And he was already making the changes uh that that that um,
- 9:56
- Lord Lee of Trafford: for example, I'd seen Miles Adcock in concurrent um bring about and do very successfully. And James Rath was coming from A B Dynamics, broad brush, good reputation, uh and he wouldn't have of uh come aboard Victorx in my view, you know, in the
- 10:16
- Lord Lee of Trafford: nicest way at his stage and and age of career development if he didn't think there was a real opportunity and challenge there for him, which he could you make where he could. make a a a difference. And what I'd like to ask him, uh, I think going on from that, i is is whether uh
- 10:36
- Lord Lee of Trafford: having come aboard and started to bring about some of the changes there, he he's even more excited, as it were, about the potential and and confident about the career move that he made.
- 10:49
- Unidentified speaker (UNKNOWN): Well,
- 10:49
- Unidentified speaker (speaker_2): yes, I mean I didn't
- 10:50
- Unidentified speaker (UNKNOWN): know.
- 10:50
- Unidentified speaker (speaker_2): did quite a lot of due diligence, as you'd expect, before I started in the role. And my my thesis that I was working to before I started was
- 11:00
- Unidentified speaker (speaker_2): differentiated product, great brand, well-invested facilities and capability. I mean, we've got double the production capacity, we can double revenue without adding any further capex. And and my my thesis was it was uh an execution issue. It was around historically some poor choices in terms of investment decisions
- 11:19
- Unidentified speaker (speaker_2): and the way the business was structured, very centralized business here in the UK, when only less when less than 2% of our business is in the UK. Our customers are out in Asia Pacific, they're in the US, they're in they're in Europe. And so having a centralized business didn't make a lot of sense to me. So I was thinking about how we could we restructure the business, get closer to
- 11:39
- Unidentified speaker (speaker_2): customers, in the right time zone, speaking the right language, and really driving improvement in sales. And suppose 10 months in now, that thesis has been proven out. And a few weeks ago, we held a capital markets event where we set out what had gone wrong in the business, what we're doing to fix it, and some longer-term longer term sort of
- 11:59
- Unidentified speaker (speaker_2): five-year financial guidance about where we're going to take the business. Um, so really a lot of the first 10 months in the business has been rebasing that strategy.
- 12:09
- Unidentified speaker (UNKNOWN): But
- 12:09
- Unidentified speaker (speaker_2): a lot of it of that strategy has been about internal activity. How do we improve leadership? How do we do operational transformation to reduce the cost of manufacture, improve gross margin? How do we grow the top line? How do we improve our sales teams? All of that kind of thing. So that's what I've really been focusing on. And we've we've encapsulated that now in
- 12:29
- Unidentified speaker (speaker_2): of course everyone has a a three-word slogan, which is our uh transform, grow and optimize strategy that we laid out at the capital markets event.
- 12:37
- Alex Newman: Great. And and just maybe just a little bit more about you, James. Yeah. Um what what did A B Dynamics teach you as a business? What what lessons have you brought from from your previous role? I
- 12:48
- Unidentified speaker (speaker_2): mean a very, a very different sector, a very different product. I mean, we do a lot in automotive, even within VicTrex, but um A B Dynamics was a solely automotive-based business.
- 12:57
- Unidentified speaker (UNKNOWN): Uh,
- 12:58
- Unidentified speaker (speaker_2): a product that was very much electronic software, simulation, uh, robotics, that kind of thing as well. So a slightly different product. But the interesting point there, what I'd bring across is you can have the best product in the world, but unless you can actually translate that into you know a customer requirement and in into translating that into revenue, profit, and cash, then
- 13:18
- Unidentified speaker (speaker_2): you know you're not going to get very far as a business. So, and a lot of that is about people, it's about capability, it's about having the right talent, it's about structuring it the right way, incentivizing people the right way. So a lot of what was done at A B Dynamics was taking what was a sort of an early stage post-IPO business, professionalizing it,
- 13:38
- Unidentified speaker (speaker_2): internationalizing it. and putting in place the systems and structures that you didn't expect in a larger business.
- 13:44
- Unidentified speaker (UNKNOWN): I
- 13:44
- Unidentified speaker (speaker_2): think in some ways I've come into Vitrex and some of that needs to be reversed. We need to be a more agile, decentralized business, focused on the customer and focused on nearer-term financial performance.
- 13:57
- Unidentified speaker (UNKNOWN): I
- 13:57
- Unidentified speaker (speaker_2): think one of the things that was clear to me when I joined the business is that we've we s we had a lot of our resources. and therefore our costs associated with much longer-term projects. They were previously referred to as mega projects or mega programs. Um
- 14:12
- Unidentified speaker (UNKNOWN): and
- 14:13
- Unidentified speaker (speaker_2): all of those are valid things to be working on, but they're all sort of over the planning horizon in terms of return and have been going on for a long time. So I've refocused the business on to nearer-term nearer term opportunities where we can translate these great capabilities of uh properties of peak into customer solutions that will deliver responses within our planning
- 14:32
- Unidentified speaker (speaker_2): horizon.
- 14:33
- Alex Newman: Okay. Great. So I mean just I mean you you you said that the the at the Capital Markets Day, you sort of unveiled that and put it in a f a five-year strategy wrapping. Just just on two of those ones. One on capital allocation, and second on on terms of marketing, what what what does what that mean? then? What have you been doing for your to the sales
- 14:53
- Alex Newman: teams and how you're restructuring? Is that just about bulking up in the various regions where you are you you are actually have your customers and uh and how does that relate to capital?
- 15:04
- Unidentified speaker (speaker_2): Yeah, a a lot of this
- 15:05
- Unidentified speaker (UNKNOWN): is
- 15:05
- Unidentified speaker (speaker_2): quite simple. Okay. There's nothing really complex here what we're doing. I mean getting back to basics. First the first point I'd like to raise before I get into the the sales teams actually is that we had there was a perception of Vitrex that we we produce parts.
- 15:19
- Unidentified speaker (UNKNOWN): So
- 15:19
- Unidentified speaker (speaker_2): if you looked at any of our marketing material, which are images of peak-based parts.
- 15:24
- Unidentified speaker (UNKNOWN): And
- 15:25
- Unidentified speaker (speaker_2): we also had something called a polymer to part strategy. So therefore people thought we were doing parts.
- 15:30
- Unidentified speaker (UNKNOWN): If
- 15:30
- Unidentified speaker (speaker_2): you look to actually where we make our money, it is in actually fundamentally the polymer, which is in either a granule or a powder form, and very specialized forms. So we form it into very thin films, um, we've in thin filaments, sort of the size of a human hair, that kind of product, very specialized forms. And that's where you know all of our revenue and profit
- 15:50
- Unidentified speaker (speaker_2): comes from. We we ventured into parts, but actually we weren't really making any money. So when we looked at the portfolio, we've rebased it to focus just on polymers and forms, not parts.
- 16:00
- Unidentified speaker (UNKNOWN): And
- 16:01
- Unidentified speaker (speaker_2): so that's first of all enabled our sales. salespeople to focus on what we actually are good at and where we make our money. There were certain geographies that were, in my opinion, underserved. So take the US market in terms of the bench strength of our sales capability there. We we've needed to enhance that significantly.
- 16:22
- Unidentified speaker (speaker_2): There's so many opportunities in in in the US in all the markets that we serve. Medical was the fastest growing. medical market where innovation comes first. Aerospace defense is another area that we're really starting to get into now. Historically, never been part of Victrek's portfolio working on that. Even oil and gas, particularly with the conflict in Iran, US
- 16:41
- Unidentified speaker (speaker_2): oil and gas is thriving at the moment. So we're we're responding well to that.
- 16:45
- Lord Lee of Trafford: You don't have a plant, or do you have a plant in in the US?
- 16:48
- Unidentified speaker (speaker_2): We have a um an aerospace complex. composites manufacturing plant in Rhode Island.
- 16:53
- Lord Lee of Trafford: Right. Um
- 16:54
- Unidentified speaker (speaker_2): called T X V. Uh that's focusing on these thermoplastic composites for aerospace. So we're working on um various aerospace programmes there, including some of these uh advanced air mobility platforms, um the also called air taxis, E V Toll aircraft and things like that in that from that facility. So that that part of the the business was really quite underserved.
- 17:14
- Unidentified speaker (speaker_2): So we've really been bolstering the commercial strength there. We've already been doing really well in China. So we've been growing at nearly 20% compound in China for the last 10 years on a consistent basis, maintaining our market share in China in a growing market, even with new entrants coming to market in terms of Chinese manufacturers.
- 17:34
- Unidentified speaker (speaker_2): But other areas of Asia, Japan, Korea, particularly, for example, needed. more sales capability there to address the the markets, for example, in Japan and Korea, such as automotive, electric vehicle development, where peak has a role to play in high voltage EV architectures.
- 17:50
- Alex Newman: Okay. And and just on terms of capital allocation, was it was it okay, we need to cut back on the dividend then to fund that? Was it is is it as is it as simple as that to extend the
- 18:01
- Unidentified speaker (UNKNOWN): I mean it's not
- 18:01
- Unidentified speaker (speaker_2): it's not about funding of that. we can do that within our existing existing sort of uh capital allocation policy but there was a a bit of a mismatch between investment returns and shareholder distributions um where the dividend was uncovered um so essentially we were we were taking on debt to fund a dividend which is obviously not sustainable so we wanted to rebase base that really
- 18:21
- Unidentified speaker (speaker_2): to a level where we can get to get a bit of um bit of headroom give us some optionality as we go forward now. And we have committed to returning 250 million of our levered free cash flow generation as a minimum to to our shareholders over the course of this five year planning horizon. And that's a minimum. Any
- 18:41
- Unidentified speaker (speaker_2): surplus cash generated there that's not needed to deliver the growth plan will be returned through through other forms such as buybacks or special dividends.
- 18:49
- Alex Newman: Great. Um John, I think when you you you mentioned uh initially that you'd bought into Victrex earlier this year, it did sound like the the dividend year was fairly extreme at that point. Were you were kind of bracing for a cut or
- 19:01
- Unidentified speaker (UNKNOWN): something? Well well,
- 19:02
- Lord Lee of Trafford: I I I was hoping that it wouldn't be cut.
- 19:03
- Unidentified speaker (UNKNOWN): Okay.
- 19:04
- Lord Lee of Trafford: Uh and and you know, the I think the original comments indicated that, you know, there was every chance of being maintained, but then, you know, the decision was taken to to to cut it, which I which you know I understand. But uh that wasn't really because things weren't going well with the business, very much the opposite. I mean the you know the last trading
- 19:24
- Lord Lee of Trafford: statement was was quite encouraging. And the shares I think I bought at around seven pounds and and the shares are about nine pounds now. So you know it's it's traveled travelled well uh for for for me so far. And uh in fact I was just uh checking the last uh couple of days. It i is the is the
- 19:43
- Lord Lee of Trafford: Norge Bank now the lar your largest shareholder or
- 19:47
- Unidentified speaker (speaker_2): no, not our largest.
- 19:48
- Unidentified speaker (UNKNOWN): They they have
- 19:49
- Lord Lee of Trafford: about I think Norge have are up to about nine or ten percent now.
- 19:52
- Unidentified speaker (UNKNOWN): Yeah,
- 19:52
- Unidentified speaker (speaker_2): I think Columbia Thread Needle is still number one.
- 19:55
- Lord Lee of Trafford: Number one. Right.
- 19:56
- Unidentified speaker (UNKNOWN): I
- 19:56
- Unidentified speaker (speaker_2): mean there's always a bit of movement when you change the dividend policy between income funds
- 20:00
- Unidentified speaker (UNKNOWN): and growth.
- 20:00
- Unidentified speaker (speaker_2): But
- 20:01
- Unidentified speaker (UNKNOWN): sure.
- 20:01
- Unidentified speaker (speaker_2): We've seen a bit of a shift there. But Jim generally the the register has remained surprisingly stable over that time frame time frame.
- 20:08
- Alex Newman: How how has that been out of interest? The the investor communication piece? Did you get the sense of the capital markets day was well received from, you know, long term and and I suppose newer investors as well who might be taking a fresh look?
- 20:21
- Unidentified speaker (speaker_2): Yeah, I mean we had some excellent feedback. From my perspective, it was hugely successful. Um obviously when you make a a change in capital allocation and a and a new dividend policy, there's always going to be a response on the day. Um, but beyond that, we've we've received overwhelmingly positive response to our financial guidance and to our new capital
- 20:40
- Unidentified speaker (speaker_2): allocation policy. Um and and it is getting a lot of attention from from non non-holders holders now as well that that previously wasn't there.
- 20:49
- Alex Newman: One thing in your in your Um strategy you've set out, you obviously have to forecast as a business. You're facing lots of end markets, and you need you need stability in the investment decisions you're making over five years. How forecastable are these end markets? We live in a pretty volatile world. There are things in your control, there are things aren't in your
- 21:09
- Alex Newman: control. 5% Five percent per annum to 2031 twenty thirty one sounds like quite a quite a precise measured. maybe beatable um forecast, but at the same time,
- 21:18
- Unidentified speaker (UNKNOWN): um,
- 21:19
- Alex Newman: you know, you've you it's uh it is a lot of work and there's a lot of uncertainty still that goes into putting any number out uh like that out there. How how confident are you in in in in the forecasts you've got?
- 21:30
- Unidentified speaker (speaker_2): So so one of the things I
- 21:32
- Unidentified speaker (UNKNOWN): did
- 21:32
- Unidentified speaker (speaker_2): when I first started was a real detailed understanding of our market, our customers, our competitive position.
- 21:39
- Unidentified speaker (speaker_2): And there's an extensive piece of work being done behind the scenes there that supported those numbers. So we looked at each of our primary market sectors. What's the market growth rate for peak in those applications? Some of it is due to volumes. For example, in aerospace, the build rate of aircraft is now accelerating. So we go with that. And there's an
- 21:59
- Unidentified speaker (speaker_2): element of it that's penetration of peak, displacing other materials into those markets as
- 22:04
- Unidentified speaker (UNKNOWN): well.
- 22:05
- Unidentified speaker (speaker_2): Good example is in medical active implantable devices that are used inside the heart, for example, that communicate outside the body. Well, you can't use metals because you can't communicate with metals. So peak allows signal transmissibility between the body and the receiver. So that's an example of penetration of peak into a new and into existing
- 22:25
- Unidentified speaker (speaker_2): market. So behind that, there's a detailed piece of work.
- 22:29
- Unidentified speaker (UNKNOWN): And
- 22:30
- Unidentified speaker (speaker_2): it I know it does sound vaguely convenient that it comes out at 5%, but the there's lots of moving parts within that and and it's coming out at approximately five percent. Um so that's why we can stand behind that. Now, importantly, that guidance that we put out in terms of our our revenue growth of of five 5% percent over the cycle does not
- 22:50
- Unidentified speaker (speaker_2): include any. impact from what was previously called the mega programs. So these things like the magma, which is the oil and gas flexible pipes business, the um the knee program for medical, that does not include any of those because quantum and timing is uncertain. So we wanted to just say, look, we can deliver this without
- 23:08
- Unidentified speaker (UNKNOWN): the
- 23:08
- Unidentified speaker (speaker_2): things that have been promised in the past. If they come in, they're cream on top, they're they're in addition to that plan. So we've we feel comfortable with the guidance, the financial guidance we've given on the basis of the market characteristics, our differentiated position, the growth rates of those markets.
- 23:25
- Unidentified speaker (speaker_2): We want to put out guidance that that is conservative, prudent, that we can stand behind, that we meet and beat, given the track record over the last five years has been a series of downgrades. We want wanted it to move away from that, draw a line. under it, and then move forward from here.
- 23:41
- Lord Lee of Trafford: And you mentioned defense, I think.
- 23:43
- Lord Lee of Trafford: That's an area that you're looking at.
- 23:47
- Unidentified speaker (UNKNOWN): And
- 23:47
- Lord Lee of Trafford: you see a number of opportunities there. Do you want
- 23:49
- Unidentified speaker (UNKNOWN): to do that? Yeah,
- 23:49
- Lord Lee of Trafford: yeah. Is that what we're saying?
- 23:51
- Unidentified speaker (speaker_2): So without getting to specifics, obviously, um, this is a market where
- 23:56
- Unidentified speaker (speaker_2): higher volumes of lightweight air air structures, air aerostructures are needed that are easy to manage. manufacture, but have the right properties and characteristics. So moving away from very long-term, very difficult build programs. So just give you a statistic. So if you're talking about making structural
- 24:16
- Unidentified speaker (speaker_2): parts from peak-based thermoplastic composites, we're able to make parts in minutes to an hour, as opposed to several days in a large sort of autoclave setting. for thermosetting composites. So if you want to do things quicker, make higher volumes of certain products, this is a good solution for doing that in a
- 24:35
- Unidentified speaker (speaker_2): cost-effective way because the manufacturing time is so much shorter. But it also gives you lots more options as well in terms of the shapes you can make and how you put it together. So we're getting um quite a lot of interest in that market right now. Um, as you can imagine, um, post-Ukraine. post Ukraine and the lessons learned from that conflict and how that can be applied to to to uh
- 24:55
- Unidentified speaker (speaker_2): products kind
- 24:55
- Unidentified speaker (UNKNOWN): of.
- 24:56
- Lord Lee of Trafford: And the world of UAVs, drones, is is is that
- 25:00
- Unidentified speaker (speaker_2): that's that's clearly an area where one of
- 25:02
- Unidentified speaker (UNKNOWN): these kinds of things are.
- 25:05
- Unidentified speaker (speaker_2): Potentially.
- 25:07
- Unidentified speaker (speaker_2): Early days.
- 25:07
- Alex Newman: And y you talked about the cream on top. I don't know if it's cream or a wild card, but you you did mention also humanoid robotics. Yes. What are investors to make of that? Is that a let's see what Elon Musk decides to do in the next three years or or however that takes off? How do you sort of model that?
- 25:24
- Unidentified speaker (speaker_2): Well,
- 25:25
- Unidentified speaker (UNKNOWN): we
- 25:25
- Unidentified speaker (speaker_2): haven't modelled it. We've deliberately excluded it from our guidance. Um, because again, it's one of those ones where the end use applications are not entirely clear, um, and neither are of the volumes. What is clear though is that for anything that invests involves gearing and wear surfaces on joints and movement, peak is a perfect solution for that in terms of
- 25:45
- Unidentified speaker (speaker_2): its properties. And it's already being used in uh humanoid robots in both the US and in China.
- 25:52
- Unidentified speaker (UNKNOWN): So
- 25:52
- Unidentified speaker (speaker_2): it's already been used in those prototypes that we've seen or seen the videos of ones. You
- 25:56
- Unidentified speaker (UNKNOWN): made an appearance
- 25:57
- Alex Newman: in the robotic Olympics.
- 25:59
- Unidentified speaker (speaker_2): I can't possibly comment on that. Um now
- 26:02
- Unidentified speaker (UNKNOWN): I've
- 26:02
- Unidentified speaker (speaker_2): spent my previous role, I spent many years in vehicle autonomy and robotaxis and when they're going to appear on the roads and all this thing. And so after
- 26:12
- Unidentified speaker (UNKNOWN): I'm
- 26:12
- Unidentified speaker (speaker_2): I'm slightly skeptical of the timing associated with some of these things, which is again why I've not committed to any any kind of quantum or More inclusion in our guidance. But it's clear there's an opportunity there. I've seen wildly different forecasts about the amount of peak per robot and the numbers of robots that could be deployed. Um
- 26:32
- Unidentified speaker (speaker_2): Barclays published a note on this with some huge numbers in it only uh a few weeks ago. Uh our analysis was considerably smaller than that. But either way, it would be a material step up for us as a business should it come to the sort of volumes they're talking about.
- 26:47
- Alex Newman: But
- 26:47
- Unidentified speaker (UNKNOWN): I
- 26:47
- Alex Newman: suppose to tie that into, you know, that's the speculative. side, but to bring it back to what you were talking about capacity, you can respond if there is an if there is a new need, because
- 26:57
- Unidentified speaker (UNKNOWN): as
- 26:57
- Alex Newman: you're saying, these are things you can produce potentially in minutes once you've got the the designs for them.
- 27:02
- Unidentified speaker (speaker_2): Yeah. So we we we have eight thousand tons capacity um in the UK and an additional potentially when we get there, 1500 tons of capacity in in China. Um And and last year's numbers um in terms of volumes were early four thousands. So we do have plenty of scope to be able to respond to
- 27:22
- Unidentified speaker (speaker_2): the growth in the market.
- 27:24
- Unidentified speaker (UNKNOWN): Um one
- 27:25
- Alex Newman: thing I wanted to ask, and I don't quite I didn't quite understand this from the capital markets day, so maybe you can help me. Um one of the pillars of the sales push is what you've called um end end-to-end to end simulation. So
- 27:38
- Unidentified speaker (UNKNOWN): am I
- 27:38
- Alex Newman: getting this right? Is that to the outside of that, it sounds like you are you're working almost hand in hand with your clients in their sort of highly technical fields to innovate with them and show them how peak might be might be applied in areas they might not have identified. Is that is that roughly is that roughly
- 27:54
- Unidentified speaker (UNKNOWN): right?
- 27:55
- Unidentified speaker (speaker_2): Essentially yes. So we sometimes customers don't know how to engineer with this material.
- 28:01
- Unidentified speaker (UNKNOWN): Okay.
- 28:01
- Unidentified speaker (speaker_2): Because most engineers, I am one um, we spent our time learning how to design with metals and other materials. Now these have very different properties. And what we're able to do with our modeling and simulation capability is is in the virtual world demonstrate to the customer how this would work, what the benefits would be, you know, not not just how it would function in its application,
- 28:21
- Unidentified speaker (speaker_2): but actually how do you mold it. We actually simulate the manufacturing process to optimize that to make it
- 28:27
- Unidentified speaker (speaker_2): increase production yields and reduce manufacturing cost. So we can do things like structural analysis using finite element analysis. We can look at flow analysis of the material using computational fluid dynamics. We even do computational chemistry looking at a molecular level, Along how the material is likely to perform. So
- 28:47
- Unidentified speaker (speaker_2): we're able to simulate all of that before they commit to costly tools. tooling,
- 28:51
- Unidentified speaker (UNKNOWN): you
- 28:52
- Unidentified speaker (speaker_2): know, start making things. That's that's when costs are committed. We can do that very early in the development cycle, influence the design, and ideally, of course, um get them to select Victor XP as the solution as part of that process. So it's part of the selling process. It's part of this application's engineering bit I mentioned earlier.
- 29:09
- Unidentified speaker (UNKNOWN): Is
- 29:09
- Alex Newman: that hard getting your foot in the door then? Because that's that sounds like a that's that's different to having a I suppose uh a a big big purchase order or a tender that you're you're almost getting in.
- 29:19
- Unidentified speaker (UNKNOWN): We're getting very early
- 29:21
- Unidentified speaker (speaker_2): very early. Exactly. That's why customer relationships and having close customer partnerships important. We want them to come to us and tell us we're thinking of this product in five years' time. Okay, how do we start working on that with you now so that we are entrenched in their process, we become specified in as part of that, and then the barriers to
- 29:41
- Unidentified speaker (speaker_2): entry are much higher for our competition.
- 29:43
- Unidentified speaker (UNKNOWN): John,
- 29:43
- Alex Newman: I I oh I can this, I suppose, an open question really. I mean, we've talked a little about the number of you know, the global breadth of Victrex. It's it's servicing markets in the China in China, in the US.
- 29:55
- Unidentified speaker (UNKNOWN): It's
- 29:56
- Alex Newman: getting a more complicated world, trade barriers going up, tariffs, negotiating negotiation. negotiating all of this I imagine is is is fairly
- 30:06
- Unidentified speaker (UNKNOWN): uh
- 30:06
- Alex Newman: fairly challenging. Um
- 30:09
- Unidentified speaker (UNKNOWN): I
- 30:09
- Alex Newman: suppose I suppose uh I supp I suppose um uh to you James I mean the the are there contradictions in in in the the the global markets you're you're solving and how are you getting around them and John how how how are you feeling about uh Vic uh Victoric's Victor X being you
- 30:26
- Unidentified speaker (UNKNOWN): know
- 30:26
- Alex Newman: so globally exposed and
- 30:27
- Lord Lee of Trafford: well uh I I mean I I welcome the you know the the global aspect of it. I mean I I I think as you know uh I'm I'm uh solely focused on UK equities. Uh now people say to me well you know aren't you missing the growth opportunities in in Asia or the US or what have you? And I say of course I'm not uh because
- 30:48
- Lord Lee of Trafford: you know the majority of the businesses that I'm invested in like Victrex, you know, actually are trading globally, but have the advantage of a UK quote and and UK integrity for the sake of argument. So uh I'm relying on on the Victrexes to uh you
- 31:08
- Lord Lee of Trafford: know to put their uh shoulder and their effort into growing markets in the third world and into the US, obviously. from a defense and medical point of view, huge huge markets there. And uh I hadn't I hadn't in fact appreciated until we were talking today uh and interviewing James that you know the UK was only two percent
- 31:28
- Lord Lee of Trafford: of revenue. So I mean that makes that just makes my makes my case that that that that I'm investing in a UK quoted company, but you know, look, it's trading 98% globally. Uh so you know it it really ticks that box. Can I ask just one question on on competition, James? I think you said that
- 31:47
- Lord Lee of Trafford: in was it was it peak one you have no competitors or peak two?
- 31:52
- Unidentified speaker (UNKNOWN): Yeah,
- 31:52
- Unidentified speaker (speaker_2): type one we have no competitors.
- 31:53
- Lord Lee of Trafford: No competitors. And and peak two a number of competitors.
- 31:57
- Unidentified speaker (speaker_2): Yeah, there are were two Western competitors. Right. Um based based in Europe, um both of which manufacture
- 32:03
- Unidentified speaker (speaker_2): um in a combination of China and India. And then we have now seven Chinese competitors, many of them very early stage, and they generally have struggled with the complex synthesis of peak. Um, there's one that's kind of come out the other end of that now. They do have a product that is reliable. Um, they have
- 32:23
- Unidentified speaker (speaker_2): around fifteen 1500 hundred tons of capacity.
- 32:26
- Unidentified speaker (UNKNOWN): Um
- 32:27
- Unidentified speaker (speaker_2): But we have virtually zero examples of where we've lost business to them, certainly outside of China. And like I said, we've grown in China consistently and maintained our market share. So competitively, you know, we have to keep you a very close eye on it, of course. And China is always evolving in terms of their capability. We need to make sure that we're aware of that. But fundamentally, I think we're
- 32:47
- Unidentified speaker (speaker_2): in a pretty good position from a competitive standpoint. And to your question around
- 32:53
- Unidentified speaker (speaker_2): the new normal, should we call it that?
- 32:56
- Unidentified speaker (speaker_2): Geopolitics, macroeconomics is constantly changing on a daily basis. I think everyone that runs a business these days that's international just has to get used to it. It's just normal. One of the interesting points in when I'm talking about things like uh tariffs and trade policies, um sometimes the UK has a uh sort
- 33:16
- Unidentified speaker (speaker_2): of a neutral position in all of this, and you can take advantage of that. So, for example, into the US, we're able now to supply not quite tariff free, but almost. Um, whereas, of course, our Chinese competitors cannot. Um, all the the Chinese government recently announced a 13% Percent VAT on all exports
- 33:36
- Unidentified speaker (speaker_2): of peak from the UK. So, although they've got a lower cost. base, that has disadvantaged them than when they go outside of China, which means of course they double down inside China. But it means they're less likely to be sort of trying to enter markets outside of China. But I I just think we've been in almost permanent crisis since COVID. And it's just
- 33:56
- Unidentified speaker (speaker_2): normal for in terms of running a business these days.
- 33:58
- Lord Lee of Trafford: When the shares were were flattering flatter in the around the seven pound level, I mean just was there a vulnerability do you think to a to a a predator? I mean given the you know the the worth of the business, the, you know, the technology uh that is there as it were, you know, was was there a a a predator risk do you think, which ha has to be still there
- 34:18
- Lord Lee of Trafford: to some extent, I suppose?
- 34:20
- Unidentified speaker (UNKNOWN): Well
- 34:21
- Unidentified speaker (speaker_2): the the the share price was lower than seven of course, uh uh at one point earlier this year. Um considerably lower, actually. So there was all there's always going to be a vulnerability around that point, whether it be to private equity or or larger strategics. Um what Victor X does is quite unique. Um it is it is a prize.
- 34:40
- Unidentified speaker (speaker_2): Um and my my my mission of course is to make sure that doesn't happen happen and to make sure that we we get the share price to a point where that becomes unattractive.
- 34:49
- Unidentified speaker (UNKNOWN): Sure.
- 34:49
- Unidentified speaker (speaker_2): Um which we've been working on. So I think we've seen a 60% increase in share price since June approximately, around that kind of level. So that makes us less
- 34:58
- Unidentified speaker (UNKNOWN): can I ask
- 34:59
- Lord Lee of Trafford: do you have do you have a a growing shareholding yourself?
- 35:02
- Unidentified speaker (speaker_2): Yes, I do.
- 35:03
- Lord Lee of Trafford: Outside share options.
- 35:06
- Unidentified speaker (speaker_2): Well I acquired some before I before
- 35:08
- Unidentified speaker (UNKNOWN): I
- 35:08
- Unidentified speaker (speaker_2): started back in December. So I started in January. So I acquired some at of that point. Um And um I obviously have to wait had till the results were out in December. Um and then of course the share options have been awarded. And at the appropriate time, when I'm not in a closed period, then I'll seek to do some more.
- 35:23
- Unidentified speaker (UNKNOWN): Sure. Um
- 35:25
- Alex Newman: just to return to your point on the on the on the sort of perma crisis we're living in. I mean, one when talking about the UK chemicals sector or specialty chemicals even,
- 35:33
- Unidentified speaker (UNKNOWN): I mean,
- 35:33
- Alex Newman: a mainstay is that energy prices in the UK have been have been harmful.
- 35:37
- Unidentified speaker (UNKNOWN): Do
- 35:38
- Alex Newman: they affect your business? business uh to the same degree that we sort of talk about in general terms, or is it the nature of your your pricing and your margins mean that you're you're relatively resistant to
- 35:50
- Unidentified speaker (speaker_2): one thing I want to try and make really clear is that we know we we're not a commodity chemicals company. You know, we are a high margin Specialized specialised material solutions company. And so as such, our margins uh our operating margins are much higher than you'd expect to see in some of those other areas. Around 4% of our revenue is spent
- 36:10
- Unidentified speaker (speaker_2): on energy.
- 36:12
- Unidentified speaker (speaker_2): So it's still a decent chunk, and it does have an impact, of course, if that goes up significantly, it gets dropped straight through to the bottom line.
- 36:19
- Alex Newman: Is that power or gas? What's the what's the main? mix of
- 36:21
- Unidentified speaker (UNKNOWN): case? It's it's
- 36:22
- Unidentified speaker (speaker_2): predominantly It's a mix of of electricity and gas. And we we run a large chemical process. plant plant app in Lancashire that uses boilers, which requires gas. Uh at present, of course, we are looking at alternatives all the time from both a sustainability and cost effectiveness standpoint. But the way it's set up at the moment, we do consume gas and we do consume um high proportions of
- 36:41
- Unidentified speaker (speaker_2): electricity. So it is an impact, but far less than the the the sort of higher volume, more commoditised commoditized chemicals companies you see elsewhere in the UK.
- 36:51
- Unidentified speaker (UNKNOWN): I
- 36:52
- Alex Newman: suppose that only that just leaves me to ask John John, you always have a rounding question, which I know you've sort of pre-warned James about. Yeah,
- 36:58
- Unidentified speaker (UNKNOWN): so you've sat
- 36:59
- Lord Lee of Trafford: down and think about it. Yes, uh and the question is and and uh listeners will will know. T James, taking into account all that you can tell me and what you can't tell me, where where do you put yourself on a on a on an optimum optimism scale for Vic Victrex train? uh on a one to ten? In other words, one being very
- 37:18
- Lord Lee of Trafford: pessimistic about the business and and ten being very optimistic about the business. Um you know, where would you where would you put yourself?
- 37:28
- Unidentified speaker (UNKNOWN): I
- 37:29
- Unidentified speaker (speaker_2): think that that that's changed um since January when I started. I would have I would have put it sort of in in the middle of that spectrum when I started because there was still a lot I needed to understand and know. I would say we're now at the nine ten end of the spectrum. You know, we we have done already a lot uh in terms of the restructuring of the business and improvement
- 37:47
- Unidentified speaker (UNKNOWN): of leaders.
- 37:49
- Lord Lee of Trafford: Nine plus
- 37:49
- Unidentified speaker (UNKNOWN): nine plus.
- 37:50
- Unidentified speaker (speaker_2): Very
- 37:50
- Unidentified speaker (UNKNOWN): good,
- 37:50
- Unidentified speaker (speaker_2): John.
- 37:51
- Unidentified speaker (UNKNOWN): We would
- 37:51
- Lord Lee of Trafford: go along with that.
- 37:52
- Unidentified speaker (UNKNOWN): Yeah.
- 37:52
- Unidentified speaker (speaker_2): Well, look, I mean I I spelled it out at the capital markets event. Um and I've I've given some clear financial guidance that that I believe that we can we can deliver.
- 38:01
- Unidentified speaker (UNKNOWN): Um
- 38:02
- Unidentified speaker (speaker_2): so therefore based on everything I've seen, based on where we are right now, speaking to customers, what they're telling us, and our financial performance up to date. I'm confident of that delivery.
- 38:12
- Lord Lee of Trafford: Would you would you use the word excited about
- 38:16
- Unidentified speaker (UNKNOWN): prospects?
- 38:17
- Unidentified speaker (speaker_2): There's lots of opportunity in this business.
- 38:19
- Unidentified speaker (UNKNOWN): And no
- 38:19
- Lord Lee of Trafford: regrets about taking on making
- 38:21
- Unidentified speaker (UNKNOWN): the move.
- 38:21
- Unidentified speaker (speaker_2): Certainly not. No. I I'm
- 38:23
- Unidentified speaker (UNKNOWN): there
- 38:24
- Unidentified speaker (speaker_2): There are so many levers we can pull as a business, both in terms of some of the internal stuff, optimising the business, taking costs out, exiting some of our loss making businesses, as well as the growth side of things as well, that's really going to deliver the outcomes that we're looking
- 38:36
- Unidentified speaker (UNKNOWN): for.
- 38:37
- Lord Lee of Trafford: Good.
- 38:38
- Alex Newman: Great. Very bullish note to end on.
- 38:40
- Lord Lee of Trafford: Well done, yes. Very encouraging. Good luck. Thank
- 38:42
- Unidentified speaker (UNKNOWN): you.
- 38:42
- Alex Newman: Yeah, thank you, James, for for coming on. So, John, in the time we've got left, uh, let's just take a moment to check in on your your broader portfolio. I mean, the big news development since we spoke at the end of September was that you're out of the aforementioned Goodwin.
- 38:56
- Lord Lee of Trafford: Yes, not totally,
- 38:57
- Unidentified speaker (UNKNOWN): but I sold a bulk of
- 38:58
- Lord Lee of Trafford: my holding and still made a very good profit on it. And I have to be very thankful. But obviously the uh
- 39:05
- Unidentified speaker (UNKNOWN): we
- 39:05
- Lord Lee of Trafford: were dealing are dealing with a totally new situation with the with the you know the the agreed sale of the uh the defence business. And uh you know there was concern. about the directors moving abroad personally. Um there was also concern and I was somewhat concerned when they announced that they were uh uh going
- 39:25
- Lord Lee of Trafford: to appoint a chief executive and a finance director because for me, um, you know, the the big plus for Goodwin's when I visited w was the the the you know terrific enthusiasm for um you know by the the f the four members of the family who were of the next generation
- 39:45
- Lord Lee of Trafford: who were running the business and and you know I I thought it was an extraordinary from f family business. Normally you find one person who you know is really the keen person uh and really keen and the rest on the board border are sort of so-so. Whereas in Goodwin's case, you know, all of the all of the generation running the business were really
- 40:05
- Lord Lee of Trafford: committed to it. And this was one of the reasons why I was so excited about it. And, you know, let's be realistic. I mean, they have delivered great performance over the years. But then with with the announcement of the sale, which I think took everyone by surprise, one had to r reassess. And uh it just seemed
- 40:25
- Lord Lee of Trafford: to me that that there were a number of unsatisfactory. uncertainties creeping in. Um, no one really knows whether Develco, which is their very high temperature polymer, is going to be a uh a success and how big, then they've got the um the lithium fire extinguisher side, which they believe will be substantial, and and these could be
- 40:44
- Lord Lee of Trafford: very valuable. And of course, the present price is broadly underpinned by the um by the sale proceeds, if it if it gets regulatory approval and goes through. But there were some uncertainties. So I I just took the view that that really things had changed and you know that
- 41:04
- Lord Lee of Trafford: I would take my profit and and move on. Not sure it Surely looking back it was the correct thing to do, but I'm nevertheless that was the decision I I I took. I think since then the price has risen uh a little. Um I've still got a few shares, but not as many as I had. But it that also gave me an opportunity to redeploy quite a bit of
- 41:24
- Lord Lee of Trafford: money across a number of new investment opportunities uh as I saw them. Uh and so overall, you know, I think it was the right decision.
- 41:33
- Unidentified speaker (UNKNOWN): Okay,
- 41:33
- Alex Newman: and so very briefly, where have you moved on to then? Or what's the
- 41:37
- Unidentified speaker (UNKNOWN): point? Just to
- 41:37
- Lord Lee of Trafford: just to summarize. I've added to one or two of my existing holdings like uh uh Christie, for example, and Vionet, which I believe are businesses significantly undervalued, uh and and both with with considerably improving prospects. Uh I opened a new position in Big Yellow, the self storage people when when they
- 41:57
- Lord Lee of Trafford: were uh eight pounds yielding six percent and the asset value was twelve pounds. where talks I think with one of the with Blackstone or Black Rock had broken down. It seemed to me the the drift back from twelve to eight had been overdone and and the dividend E was attractive. And so I bought Big Yellow and then a couple
- 42:17
- Lord Lee of Trafford: of activists surfaced so the shares have gone through and gone back
- 42:22
- Unidentified speaker (UNKNOWN): up. And
- 42:23
- Lord Lee of Trafford: uh clearly the clearly Big Yellow is is in play to some extent. I picked up some NWF, which company I knew from the Northwest, my Northwest days, and I'd been uh in that many years ago. And they've got a number of growing businesses, no debt. It was a nice 6% yield. And
- 42:43
- Lord Lee of Trafford: their food storage business, I thought, had very considerable potential. And an activist has appeared on the share register, Canadian activists, only. owning about 10%. So we'll see what happens there. And I thought also our birth knot banking looked very cheap, very good results. Um Henry Angst, who uh controls it effectively, has built it up
- 43:03
- Lord Lee of Trafford: um uh a month or so ago, bought another quarter million pounds worth of shares, which is always an encouraging sign. I follow directors quite closely, and I was able to pick them up around the eight pound mark, uh, asset value of 17 pounds, 7%, near 7% dividend yield. So
- 43:22
- Lord Lee of Trafford: it ticked a number of boxes for me. And it seemed to me there was very little downside in the business. Who knows what will happen in the future, whether um uh Henry Anks will will sell the business at some stage, and if he were to do that, but it's I think it's a very valid. valuable trophy. Uh very difficult to buy a quality bank
- 43:42
- Lord Lee of Trafford: these days. Uh and it would fetch, I'm sure, a very attractive price. But even if that doesn't happen, I think there is considerable growth in it. And uh, as I said, I was encouraged by his
- 43:55
- Unidentified speaker (UNKNOWN): uh
- 43:55
- Lord Lee of Trafford: his share performance. So uh
- 43:58
- Unidentified speaker (UNKNOWN): a
- 43:58
- Lord Lee of Trafford: good opportunity to redeploy
- 44:00
- Unidentified speaker (UNKNOWN): the
- 44:00
- Lord Lee of Trafford: SEM some funds across a number of uh new opportunities.
- 44:03
- Unidentified speaker (UNKNOWN): Yeah,
- 44:03
- Alex Newman: excellent. We look forward to hopefully speaking with a few of them in the in the coming months. Um we've also had one listener question from Robert on um on Cerulean, the the that's the provider of billing, charging and and C R M solutions for large global telcos. Uh they've been having a rather tricky time of late, which I think has prompted his question on
- 44:23
- Alex Newman: whether you remain confident in their their long long-term term prospects and and whether you feel the share price adequ adequately reflects
- 44:30
- Unidentified speaker (UNKNOWN): where
- 44:31
- Alex Newman: they're at or if uh or if that has left now left them undervalued.
- 44:34
- Lord Lee of Trafford: Well the shares have come down from about £20 to about uh seven
- 44:38
- Unidentified speaker (UNKNOWN): pounds just
- 44:39
- Lord Lee of Trafford: over just over seven. Thankfully uh you and I was in uh right at the start a lot lower than that so it's still to still turn turned out to be very good investment and I did sell some higher up. Um but uh, you know, I think there has been a short-term plateau uh in terms of new orders, uh new contracts.
- 44:59
- Lord Lee of Trafford: Uh, and I think uh all shareholders, including me, have been waiting and hoping for this this pipeline uh of opportunities which Louis Hall has talked about actually coming through to you know to to fruition. He's very uh he's very optimistic long term about the business.
- 45:18
- Unidentified speaker (UNKNOWN): Uh
- 45:18
- Lord Lee of Trafford: short term, who knows? But uh a couple of weeks ago, uh one of the non-executive directors, uh, who I gather was one of the founding directors originally bought 140,000 pounds worth of of shares at around this the present level, uh which I took to be a very encouraging.
- 45:38
- Lord Lee of Trafford: sign because he clearly knows where the business is up to, and he would probably know it as well, uh, as probably as well, or maybe even better than Louis Hall, being a little bit little bit more back as a non-executive rather than executive. And the fact that he was prepared to commit that sort of money, which is
- 45:58
- Lord Lee of Trafford: quite a lot for a even you know, even for a wealthy non-executive, I took to be very encouraging. And so uh I would be I'd be disappointed if if um you know there aren't one or two new contracts announced in the short term. And I think if if if there are one or two good ones announced, um then I think the shares could recover quite significantly
- 46:18
- Lord Lee of Trafford: quite quickly.
- 46:19
- Unidentified speaker (UNKNOWN): Okay.
- 46:19
- Alex Newman: Well I hope that answers you.
- 46:21
- Unidentified speaker (UNKNOWN): So I uh so
- 46:21
- Lord Lee of Trafford: I'm certainly staying aboard. Yeah.
- 46:23
- Unidentified speaker (UNKNOWN): And
- 46:23
- Lord Lee of Trafford: that's what I would recommend Robert to do.
- 46:25
- Alex Newman: Okay. Great.
- 46:26
- Unidentified speaker (UNKNOWN): Well
- 46:26
- Alex Newman: that's about all we've got time for this month. Um, we'll be back in early December with the CEO of another recent addition to John's portfolio. Any questions you'd like to put to John can be done by emailing me at alex.newman at ft.com. Until then, all that's left for me to do is to thank you for listening. Thank you, John as ever. Thank you so much, James, again, for
- 46:46
- Alex Newman: uh for coming on today, and to thank our producers, John Dowling and June. Andrew Georgiadis for their work behind the mixing desk. And until next
- 46:55
- Unidentified speaker (UNKNOWN): time.
More from Investors' Chronicle
Nvidia’s scandal, Vodafone and Labour’s new pension rules: Companies and Markets Show
Episode discussion: Nvidia CEO ousting, UK pension reforms, and Vodafone downgrade
Speakers’ claims: The episode covers the ousting of Nvidia CEO Jensen Huang following espionage allegations, raising succession and market share concerns. It outlines UK Labour's 'guided retirement' pension proposals aimed at providing default lifelong income for savers. Vodafone's half-year results are discussed, highlighting strong organic growth but persistent issues in Germany. Finally, the analyst downgrades Vodafone to a hold, citing execution risks from the Three merger and competition from Starlink.
Midterms vs markets, what’s next for Primark and infrastructure: Companies and Markets Show
Episode discussion: Midterm election impacts, ABF/Primark spin-off, and infrastructure investment risks discussed
Speakers’ claims: Alfred James Norrington analyzes US midterm election outcomes, noting gold rallies and bond market shifts driven by trade policy expectations. Erin Wyothy reviews Associated British Foods' disappointing results, citing Primark discounting and sugar division losses ahead of a planned 2027 spin-off. Val Cipriani highlights a $106 trillion global infrastructure spending opportunity through 2040, warning investors to scrutinize fund holdings for true risk profiles.